CTP central petroleum limited

1.85%

5.5¢

Moving Target CTP, page-20

First 20 Last

Share
Profile

Follow
mg021

326 Posts.

20

14/02/18

12:20

Post #: 31046875
Share
Originally posted by brucesterfer ↑

Can you point to me where on the balance sheet this has been recorded? I can't find it in the 2017 Annual report; I'd expect this to be in note 17?

http://centralpetroleum.com.au/wp-content/uploads/2017/11/2017-Annual-Report-FINAL.pdf

I also found the relevant text in court documents which summarises the issue from QLD court. Seems pretty clear cut to me?

"Geoscience claims that it is entitled to commission, by way of a success fee, for introducing Total to Central, on the basis of a further agreement it contends was made with Central on 26 February 2012 (the 2012 agreement). Central denies that it entered into the 2012 agreement. There is a factual dispute as to whether an employee of Central, Mr Trevor Shortt, signed the 2012 agreement. Mr Shortt says he did not. The representative of Geoscience, Mr Niraj Pande, and his assistant, Mr William McGinnis, says he did. No signed copy of the alleged agreement has been produced. Central says, even if it be found that Mr Shortt did sign the agreement, which he denies, he did not have actual or ostensible authority to bind Central to the 2012 agreement. Central also relies upon the 2011 agreement, which provided that Central had no liability to pay any commission to Geoscience (cl 12) and under which Geoscience released and discharged Central in relation to any claim that Geoscience may make for payment of a commission (cl 26)."

Source: https://archive.sclqld.org.au/qjudgment/2017/QSC17-223.pdf

Looks like CTP has gone to QLD court to seek relief that texan courts don't have jurisiction over CTP activities (which is fair enough to me?). GRR sound like they're relying on the lenience of local texan courts, which often seem to favour local companies in awarding damages (refer the number of IP and patent cases from patent trolls that are exercised through these courts).

Expand

Well said Bruce. Finally someone reading and reporting the facts correctly and in context. Sad when the trolls and those with an agenda trying to distort the information for their own purpose.
CTP Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 20 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.5¢		Change 0.001(1.85%)		Mkt cap ! $40.98M

Open	High	Low	Value	Volume
5.4¢	5.5¢	5.4¢	$91.62K	1.696M

Buyers (Bids)

No.	Vol.	Price($)
1	449381	5.4¢

Sellers (Offers)

Price($)	Vol.	No.
5.8¢	6030	1

View Market Depth

No.	Vol.	Price($)
1	449381	0.054
1	100000	0.053
3	719000	0.052
1	800000	0.051
2	39000	0.050

Price($)	Vol.	No.
0.058	6030	1
0.059	379120	4
0.060	160000	3
0.061	100000	1
0.067	149268	1

Last trade - 15.59pm 27/06/2025 (20 minute delay)

CTP (ASX) Chart

Moving Target CTP, page-20

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Moving Target CTP, page-20

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News